Jensby, E. F., Klingenberg, S., Fredsøe, J., Fonfara, K. E., Ulhøi, B. P., Borre, M., Jochumsen, M. R., Bouchelouche, K. & Sørensen, K. D. (2026).
Training and validation of a novel 14-gene expression signature associated with prostate cancer metastasis and postoperative recurrence.
International Journal of Cancer,
158(5), 1406-1419.
https://doi.org/10.1002/ijc.70247
Bjerregaard, A. A.
, Petersen, M. W., Gormsen, L., Skovbjerg, S., Jørgensen, T. & Dantoft, T. M. (2025).
Use of welfare benefits in multiple chemical sensitivity when compared to a general population – A registry and population-based cohort study.
Journal of Psychosomatic Research,
199, Article 112431.
https://doi.org/10.1016/j.jpsychores.2025.112431
Schwarz, C. W.
, Rasmussen, M. K., Bertelsen, T., Iversen, L., Skov, L. & Loft, N. (2025).
Comparative Cancer Risk in Patients With Psoriasis Treated With Adalimumab, Secukinumab, or Ustekinumab.
JAMA Dermatology. Advance online publication.
https://doi.org/10.1001/jamadermatol.2025.3928
Silverberg, J. I., Wollenberg, A., Stein Gold, L., Yosipovitch, G., Lio, P.
, Vestergaard, C., Ständer, S., Carrascosa, J. M., Gallo, G., Casillas, M., Ding, Y., Yang, F. E., Pierce, E., Agell, H. & Del Rosso, J. (2025).
Lebrikizumab provides stable skin response with no or minimal fluctuations for up to 2 years in patients with atopic dermatitis.
Clinical and Experimental Dermatology. Advance online publication.
https://doi.org/10.1093/ced/llaf490
Dulai, A. S., Murase, E. M., Avallone, G., Ferrucci, S. M., Marzano, A. V., Ribero, S., Ardern-Jones, M., Ko, E., Flohr, C., Leshem, Y. A.
, Deleuran, M., Vestergaard, C., Hijnen, D., Md, J. B., Elman, S. A., Pruneddu, S., Butler, D., Chovatiya, R., Girolomoni, G. ... Murase, J. E. (2026).
International Multi-Center Case Series of Gestational Dupilumab Exposure in the Treatment of Atopic Dermatitis: Maternal Complications and Fetal Outcomes.
Journal of the American Academy of Dermatology,
94(3), 936-940.
https://doi.org/10.1016/j.jaad.2025.10.123
Zhang, D. G., Nielsen, M.-L., Sørensen, J. A., Naassan, S., Pedersen, N. H., Østergaard, C. E. S.
, Vestergaard, C., Ali, Z., Thyssen, J. P., Egeberg, A. & Thomsen, S. F. (2025).
Early response patterns on omalizumab predict long-term outcomes in chronic spontaneous urticaria.
Journal of the European Academy of Dermatology and Venereology : JEADV. Advance online publication.
https://doi.org/10.1111/jdv.70158